Rates and determinants of COVID-19 vaccine uptake among people living with HIV in Federal Capital Territory, Nigeria.

IF 1.9 4区医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Transactions of The Royal Society of Tropical Medicine and Hygiene Pub Date : 2024-11-19 DOI:10.1093/trstmh/trae094

Victoria Peter Etuk, Charity Sanni, Oluwafemi Omonijo, Stella Ijioma Atema, Temitayo Lawal, Anthonia Murna Yashim-Ankut, Ifeyinwa Ejinkeonye, Henry Chijioke Onyegbutulem, Oyewole K Oyedele, Imoiboho Williams, Nifarta Peingurta Andrew, Evaezi Okpokoro

{"title":"Rates and determinants of COVID-19 vaccine uptake among people living with HIV in Federal Capital Territory, Nigeria.","authors":"Victoria Peter Etuk, Charity Sanni, Oluwafemi Omonijo, Stella Ijioma Atema, Temitayo Lawal, Anthonia Murna Yashim-Ankut, Ifeyinwa Ejinkeonye, Henry Chijioke Onyegbutulem, Oyewole K Oyedele, Imoiboho Williams, Nifarta Peingurta Andrew, Evaezi Okpokoro","doi":"10.1093/trstmh/trae094","DOIUrl":null,"url":null,"abstract":"Background: We investigated coronavirus disease 2109 (COVID-19) vaccine uptake and determinants among people living with human immunodeficiency virus (PLHIV) in Federal Capital Territory (FCT), Nigeria.Methods: This was a cross-sectional study among PLHIV attending antiretroviral therapy clinics in FCT, Nigeria. We utilized an interviewer-administered, semi-structured questionnaire to collect data on COVID-19 vaccine uptake. Vaccine uptake was measured using the question 'Have you received a COVID-19 vaccine?' and was confirmed with a vaccination card by the interviewer. Data were analysed using descriptive statistics, χ2 and binary logistic regressions in Stata version 18.0.Results: Of the 252 study participants, 87 (34.5%) had received at least one dose of a COVID-19 vaccine, with uptake lower in females than males (30.5% vs 46.1%; p=0.022). Being >50 y of age (adjusted odds ratio [aOR] 2.870 [95% confidence interval {CI} 1.049 to 7.858], p=0.040) was associated with higher vaccine uptake, while being virally unsuppressed (aOR 0.313 [95% CI 0.099 to 0.985], p=0.047) and not believing COVID-19 disease is real (aOR 0.324 [95% CI 0.147 to 0.717], p=0.005) were associated with lower odds of vaccine uptake.Conclusions: Vaccination uptake was low among PLHIV in our study. It is critical to target vaccination campaigns to PLHIV, particularly females and younger people. Proper education about COVID-19 itself would contribute to vaccine uptake.","PeriodicalId":23218,"journal":{"name":"Transactions of The Royal Society of Tropical Medicine and Hygiene","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transactions of The Royal Society of Tropical Medicine and Hygiene","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/trstmh/trae094","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Background: We investigated coronavirus disease 2109 (COVID-19) vaccine uptake and determinants among people living with human immunodeficiency virus (PLHIV) in Federal Capital Territory (FCT), Nigeria.

Methods: This was a cross-sectional study among PLHIV attending antiretroviral therapy clinics in FCT, Nigeria. We utilized an interviewer-administered, semi-structured questionnaire to collect data on COVID-19 vaccine uptake. Vaccine uptake was measured using the question 'Have you received a COVID-19 vaccine?' and was confirmed with a vaccination card by the interviewer. Data were analysed using descriptive statistics, χ2 and binary logistic regressions in Stata version 18.0.

Results: Of the 252 study participants, 87 (34.5%) had received at least one dose of a COVID-19 vaccine, with uptake lower in females than males (30.5% vs 46.1%; p=0.022). Being >50 y of age (adjusted odds ratio [aOR] 2.870 [95% confidence interval {CI} 1.049 to 7.858], p=0.040) was associated with higher vaccine uptake, while being virally unsuppressed (aOR 0.313 [95% CI 0.099 to 0.985], p=0.047) and not believing COVID-19 disease is real (aOR 0.324 [95% CI 0.147 to 0.717], p=0.005) were associated with lower odds of vaccine uptake.

Conclusions: Vaccination uptake was low among PLHIV in our study. It is critical to target vaccination campaigns to PLHIV, particularly females and younger people. Proper education about COVID-19 itself would contribute to vaccine uptake.

查看原文本刊更多论文

尼日利亚联邦首都区艾滋病毒感染者接种 COVID-19 疫苗的比例和决定因素。

背景：我们调查了尼日利亚联邦首都特区（FCT）人类免疫缺陷病毒感染者（PLHIV）对冠状病毒病 2109（COVID-19）疫苗的接受情况和决定因素：这是一项横断面研究，研究对象是在尼日利亚联邦首都区抗逆转录病毒治疗诊所就诊的人类免疫缺陷病毒感染者。我们采用由访谈者主持的半结构化问卷收集有关 COVID-19 疫苗接种情况的数据。疫苗接种情况是通过 "您是否接种过 COVID-19 疫苗？使用Stata 18.0版本的描述性统计、χ2和二元逻辑回归对数据进行分析：在 252 名研究参与者中，87 人（34.5%）至少接种过一剂 COVID-19 疫苗，女性的接种率低于男性（30.5% 对 46.1%；P=0.022）。年龄大于 50 岁（调整后的几率比 [aOR] 2.870 [95% 置信区间 {CI} 1.049 至 7.858]，p=0.040）与较高的疫苗接种率相关，而病毒未抑制（aOR 0.313 [95% CI 0.099 to 0.985]，p=0.047）和不相信 COVID-19 疾病是真实的（aOR 0.324 [95% CI 0.147 to 0.717]，p=0.005）则与较低的疫苗接种率相关：结论：在我们的研究中，艾滋病毒感染者接种疫苗的比例较低。结论：在我们的研究中，PLHIV 的疫苗接种率较低。针对 PLHIV（尤其是女性和年轻人）开展疫苗接种活动至关重要。对 COVID-19 本身进行适当的教育将有助于提高疫苗接种率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Transactions of The Royal Society of Tropical Medicine and Hygiene 医学-公共卫生、环境卫生与职业卫生

CiteScore

4.00

自引率

9.10%

发文量

115

审稿时长

4-8 weeks

期刊介绍： Transactions of the Royal Society of Tropical Medicine and Hygiene publishes authoritative and impactful original, peer-reviewed articles and reviews on all aspects of tropical medicine.